These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 15651211)

  • 1. Fingerprinting cancer development.
    Potera C
    Environ Health Perspect; 2003 Aug; 111(11):A572. PubMed ID: 14694892
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma proteomic pattern as biomarkers for ovarian cancer.
    Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; Yu MH; Chu TY
    Int J Gynecol Cancer; 2006; 16 Suppl 1():139-46. PubMed ID: 16515582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].
    Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310
    [No Abstract]   [Full Text] [Related]  

  • 4. Early detection of epithelial ovarian cancer using a proteomics-based protein-profiling approach combined with a novel selection strategy.
    Kothandaraman N; Bajic VB; Loganath A; Koh S; Ng J; Choolani M; Razvi K
    Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S59-60. PubMed ID: 15651211
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and validation of a protein-based signature for the detection of ovarian cancer.
    Kim K; Visintin I; Alvero AB; Mor G
    Clin Lab Med; 2009 Mar; 29(1):47-55. PubMed ID: 19389550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteomics and biomarkers for detection of ovarian cancer].
    Kacerovský M; Tambor V; Lenco J; Tosner J
    Ceska Gynekol; 2009 Jun; 74(3):163-70. PubMed ID: 19642513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
    Nossov V; Amneus M; Su F; Lang J; Janco JM; Reddy ST; Farias-Eisner R
    Am J Obstet Gynecol; 2008 Sep; 199(3):215-23. PubMed ID: 18468571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progress in applying proteomics technology to explore early diagnosis biomarkers of breast cancer, lung cancer and ovarian cancer.
    Luo L; Dong LY; Yan QG; Cao SJ; Wen XT; Huang Y; Huang XB; Wu R; Ma XP
    Asian Pac J Cancer Prev; 2014; 15(20):8529-38. PubMed ID: 25374164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying proteomics in clinical trials: assessing the potential and practical limitations in ovarian cancer.
    Tchabo NE; Liel MS; Kohn EC
    Am J Pharmacogenomics; 2005; 5(3):141-8. PubMed ID: 15952868
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.